To access all features of this site, you must enable Javascript. Here are the instructions for enabling Javascript in your web browser.
To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
Within the Institute, the "Funding Research and Technology Transfer" team is at your disposal to identify the scientists and the skills you need to set up a joint project, to define the terms of a collaboration contract or study. Whether you are an academic, a SME or an industrialist, our team informs and advices you about the possibilities of consortium assembly, technology transfer, patent licensing or use of our platforms. The team is also at the disposal of the researchers of the institute to accompany them in achieving their valorization objectives.
All the news of the Institute of life sciences Frédéric Joliot
Press kits
Selon son étude publiée dans Neurobiology of Aging, l'analyse de la morphologie des sillons corticaux permettrait de reconnaître la maladie d'Alzheimer dans 91 % des cas.
L’aimant du projet Iseult, en installation à Neurospin (CEA Paris-Saclay), a atteint son champ nominal de 11,7 teslas (T) le 18 juillet 2019. Il s’agit d’un record mondial pour un aimant IRM humain corps entier, qui vient couronner des années de R&D, à la pointe de l’innovation dans le domaine des aimants supraconducteurs.
Les flippases sont des protéines membranaires qui participent au maintien d’une asymétrie lipidique entre les deux « couches » des membranes cellulaires. L’étude, publiée le 26 juin 2019 dans Nature, permet de comprendre le mécanisme de régulation de ces protéines membranaires.
Le CEA et Zionexa ont signé un accord de licence exclusive pour l’enregistrement puis la commercialisation d’un radiopharmaceutique innovant, la Fludarabine marquée au fluor 18 ([18F] Fludarabine).
Les résultats de l'étude indiquent une densité dendritique augmentée dans le cortex frontal des patients traités par lithium.
The Iseult project magnet being installed at Neurospin (CEA Paris-Saclay) reached a nominal magnetic field of 11.7 teslas (T) on July 18, 2019. This is a world record for a whole-body magnetic resonance imager (MRI) magnet, the culmination of years of R&D, at the forefront of innovation in the field of superconducting magnets.
In the conscious state, different areas of the brain, even though not physically connected, can be activated simultaneously, achieving a rich repertoire of brain activities. Under general anesthesia, this property is blocked. Regardless of the type of the anesthetic agent, general anesthesia led to a rigid inflexible configuration of information flow within the brain: brain activity is maintained, but is restricted to physical anatomical connections, leaving it without the possibility of generating more flexible information flows.
A CEA research team, headed by Denis Le Bihan, has just used diffusion MRI to reveal the connection between the level of neuronal activity in regions concerned by wake-sleep states in anesthetized rats, and the degree of neuronal swelling in these regions.
A French team has discovered an enzyme which allows microalgae to convert certain of their constituent fatty acids into hydrocarbons using light energy.
On Thursday, 2017 May 4, a giant magnet weighing 130 metric tons will leave the assembly plants in Belfort on its journey to the NeuroSpin research facility at the CEA's Paris-Saclay Center (Essonne).
Top page
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.
